Appearing as a promising breakthrough in the fight against obesity, the drug is capturing considerable buzz. It combines the action of two known GLP-1 binding agonists, semaglutide , and an new glucose-dependent hormonal component. Initial study findings have demonstrated significant weight decrease in people with excessive weight, potentially … Read More